Volumen | 469.849 |
|
|||||
News | - | ||||||
Tageshoch | 1,6366 | Niedrig Hoch |
|||||
Tagestief | 1,53 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Milestone Pharmaceuticals Inc | MIST | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
1,60 | 1,53 | 1,6366 | 1,54 | 1,58 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
923 | 469.849 | US$ 1,56 | US$ 734.379 | - | 1,33 - 4,44 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
01:55:09 | formt | 130 | US$ 1,58 | USD |
Finanzwerte MIST
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
51,56M | 33,48M | - | 1M | -59,69M | -1,78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Milestone Pharmaceuticals
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
04.3.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
01.3.2024 | 22:52 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
29.2.2024 | 13:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Pricing of $30.0 Million.. |
28.2.2024 | 22:37 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Proposed Public Offering.. |
26.2.2024 | 13:06 | Edgar (US Regulatory) | Form 8-K - Current report |
15.2.2024 | 02:56 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
14.2.2024 | 13:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
26.12.2023 | 14:54 | Dow Jones News | Milestone Pharmaceuticals Shares Sink 24% After Receiving.. |
26.12.2023 | 13:57 | Dow Jones News | Milestone Pharmaceuticals' Etripamil Nasal Spray Application.. |
26.12.2023 | 13:15 | Edgar (US Regulatory) | Form 8-K - Current report |
21.11.2023 | 13:00 | PR Newswire (US) | Milestone Pharmaceuticals to Present at the Piper Sandler.. |
13.11.2023 | 13:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Milestone Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
MIST Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 1,65 | 1,72 | 1,50 | 1,62 | 90.936 | -0,07 | -4,24% |
1 Monat | 1,78 | 1,87 | 1,50 | 1,72 | 144.334 | -0,20 | -11,24% |
3 Monate | 1,68 | 2,40 | 1,36 | 1,73 | 333.607 | -0,10 | -5,95% |
6 Monate | 2,45 | 3,52 | 1,33 | 1,95 | 303.682 | -0,87 | -35,51% |
1 Jahr | 3,78 | 4,44 | 1,33 | 2,28 | 202.081 | -2,20 | -58,20% |
3 Jahre | 5,83 | 9,8465 | 1,33 | 4,54 | 182.950 | -4,25 | -72,90% |
5 Jahre | 15,61 | 27,73 | 1,33 | 6,50 | 493.919 | -14,03 | -89,88% |